Compare VACI & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VACI | RNAC |
|---|---|---|
| Founded | 2025 | 2007 |
| Country | United States | United States |
| Employees | 3 | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.3M | 283.2M |
| IPO Year | N/A | 2016 |
| Metric | VACI | RNAC |
|---|---|---|
| Price | $10.22 | $9.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | 203.5K | ★ 439.1K |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,797,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.86 | $5.60 |
| 52 Week High | $10.49 | $14.56 |
| Indicator | VACI | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 49.65 | 58.59 |
| Support Level | $10.07 | $9.13 |
| Resistance Level | $10.30 | $9.82 |
| Average True Range (ATR) | 0.04 | 1.19 |
| MACD | -0.01 | 0.13 |
| Stochastic Oscillator | 48.39 | 69.50 |
Viking Acquisition Corp I is a blank check company.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.